"Zentrale Notaufnahme: 24 Stunden geöffnet"

During the past decade, Oberhavel Kliniken GmbH conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oberhavel Kliniken GmbH" #1 collaborator was "Center for Clinical Trials Philipps University Marburg" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Oberhavel Kliniken GmbH" are "Breast Neoplasms" (1 trials), "Estrogen Receptor Positive Tumor" (1 trials), "Human Epidermal Growth Factor Receptor 2 Negative Tumor" (1 trials) and "Primary Invasive Breast Cancer" (1 trials). Many other conditions were trialed in "Oberhavel Kliniken GmbH" in a lesser frequency.

Most popular intervention types in "Oberhavel Kliniken GmbH" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Observation" (1 trials) and "Palbociclib + endocrine therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oberhavel Kliniken GmbH" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Oberhavel Kliniken GmbH". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Oberhavel Kliniken GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oberhavel Kliniken GmbH, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".